SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: A novel member of the expanding family of SMARCB1-deficient neoplasms

American Journal of Surgical Pathology

Volumn 38, Issue 9, 2014, Pages 1274-1281

  Agaimy, Abbas ^a   Koch, Michael ^b   Lell, Michael ^c   Semrau, Sabine ^d   Dudek, Wojciech ^b   Wachter, David L ^a   Knöll, Antje ^a   Iro, Heinrich ^b   Haller, Florian ^a   Hartmann, Arndt ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b Department of Otorhinolaryngology Head and Neck Surgery ^*  (Germany)

^c Institute for Diagnostic Radiology and Gynecologic Radiology   (Germany)

^d Departments of Radiation Therapy   (Germany)

Author keywords

basaloid carcinoma; hybrid neoplasm; INI1; rhabdoid carcinoma; sinonasal tract; SMARCB1

Indexed keywords

DNA BINDING PROTEIN; NONHISTONE PROTEIN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; ARTICLE; BIOPSY; CARCINOMA; CASE REPORT; CELL NUCLEUS; CHEMISTRY; FATALITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANASAL SINUS; PARANASAL SINUS TUMOR; PATHOLOGY; PREDICTIVE VALUE; TIME; TREATMENT OUTCOME;

ADULT; BIOPSY; CARCINOMA; CELL NUCLEUS; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARANASAL SINUS NEOPLASMS; PARANASAL SINUSES; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84906793953     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000236     Document Type: Article

References (34)

1. Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. 2012;34:877-885.
2. Haerle SK, Gullane PJ, Witterick IJ, et al. Sinonasal carcinomas: epidemiology, pathology, and management. Neurosurg Clin N Am. 2013;24:39-49.
3. Barnes L, Eveson JW, Reichart P, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005.
4. Mills SE, Fechner RE. "Undifferentiated" neoplasms of the sinonasal region: differential diagnosis based on clinical, light microscopic, immunohistochemical, and ultrastructural features. Semin Diagn Pathol. 1989;6:316-328.
5. Stelow EB, Jo VY, Mills SE, et al. A histologic and immunohistochemical study describing the diversity of tumors classified as sinonasal high-grade nonintestinal adenocarcinomas. Am J Surg Pathol. 2011;35:971-980.
6. Frierson HF Jr, Mills SE, Fechner RE, et al. Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol. 1986;10:771-779.
7. Wieneke JA, Thompson LD, Wenig BM. Basaloid squamous cell carcinoma of the sinonasal tract. Cancer. 1999;85:841-854.
8. Fritsch VA, Lentsch EJ. Basaloid squamous cell carcinoma of the head and neck: location means everything. J Surg Oncol. 2014;109: 616-622.
9. Petry KU, Menton S, Menton M, et al. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer. 2003;88: 1570-1577.
10. Fanburg-Smith JC, Hengge M, Hengge UR, et al. Extrarenal rhabdoid tumors of soft tissue: a clinicopathologic and immunohistochemical study of 18 cases. Ann Diagn Pathol. 1998;2:351-362.
11. Agaimy A, Rau TT, Hartmann A, et al. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review. Am J Surg Pathol. 2014. [Epub ahead of print].
12. Ward BE, Fechner RE, Mills SE. Carcinoma arising in oncocytic Schneiderian papilloma. Am J Surg Pathol. 1990;14:364-369.
13. Jo VY, Mills SE, Stoler MH, et al. Papillary squamous cell carcinoma of the head and neck: frequent association with human papillomavirus infection and invasive carcinoma. Am J Surg Pathol. 2009;33:1720-1724.
14. Bishop JA, Guo TW, Smith DF, et al. Human papillomavirusrelated carcinomas of the sinonasal tract. Am J Surg Pathol. 2013;37:185-192.
15. Mehrad M, Carpenter DH, Chernock RD, et al. Papillary squamous cell carcinoma of the head and neck: clinicopathologic and molecular features with special reference to human papillomavirus. Am J Surg Pathol. 2013;37:1349-1356.
16. Stelow EB, Bellizzi AM, Taneja K, et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol. 2008;32:828-834.
17. Bishop JA, Westra WH. NUT midline carcinomas of the sinonasal tract. Am J Surg Pathol. 2012;36:1216-1221.
18. Cho YM, Choi J, Lee OJ, et al. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features. Pathol Int. 2006;56:702-706.
19. Donner LR, Wainwright LM, Zhang F, et al. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium. Hum Pathol. 2007;38:935-939.
20. Kleinschmidt-DeMasters BK, Birks DK, Aisner DL, et al. Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization. Am J Surg Pathol. 2011;35:1894-1901.
21. Wick MR, Ritter JH, Dehner LP. Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion. Semin Diagn Pathol. 1995;12:233-248.
22. Kim JH, Maeng YH, Lee JS, et al. Sinonasal teratocarcinosarcoma with rhabdoid features. Pathol Int. 2011;61:762-767.
23. Hollmann TJ, Hornick JL. INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol. 2011;35:e47-e63.
24. Bittesini L, Dei Tos AP, Fletcher CD. Metastatic malignant melanoma showing a rhabdoid phenotype: further evidence of a non-specific histological pattern. Histopathology. 1992;20:167-170.
25. Perry A, Fuller CE, Judkins AR, et al. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol. 2005;18:951-958.
26. Guillou L, Wadden C, Coindre JM, et al. "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol. 1997;21:130-146.
27. Maggiani F, Debiec-Rychter M, Ectors N, et al. Primary epithelioid sarcoma of the oesophagus. Virchows Arch. 2007;451:835-838.
28. Venizelos I, Anagnostou E, Papathomas TG, et al. Proximal-type epithelioid sarcoma of the uterine corpus. Histopathology. 2011;58:321-323.
29. Frank R, Sadri N, Bhatti T, et al. Proximal-type epithelioid sarcoma of the head and neck (HN): a study with immunohistochemical and molecular analysis of SMARCB1. J Clin Exp Oncol. 2013;2:1000106.
30. Eaton KW, Tooke LS, Wainwright LM, et al. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer. 2011;56:7-15.
31. Carter JM, O'Hara C, Dundas G, et al. Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient with "neuroblastoma-like" schwannomatosis and a novel germline SMARCB1 mutation. Am J Surg Pathol. 2012;36:154-160.
32. Hulsebos TJ, Kenter S, Siebers-Renelt U, et al. SMARCB1 involvement in the development of leiomyoma in a patient with schwannomatosis. Am J Surg Pathol. 2014;38:421-425.
33. Judkins AR. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology. Adv Anat Pathol. 2007;14:335-339.
34. Tsai CY, Wong TT, Lee YH, et al. Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity. Am J Surg Pathol. 2012;36:128-133.